Intersect ENT (XENT) Misses Q1 EPS by 9c, Revenues Beat; Raises FY21 Revenues Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. FND
8. SYK
9. GILD
10. SNDK

Go back to Intersect ENT (XENT) Misses Q1 EPS by 9c, Revenues Beat; Raises FY21 Revenues Outlook

Intersect ENT Reports First Quarter 2021 Financial Results

May 10, 2021 7:00 AM EDT

Increases 2021 Revenue Guidance to $117 Million to $121 Million

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (ENT) medical technology leader dedicated to transforming patient care, today reported financial results for the first quarter ended March 31, 2021.

First Quarter 2021 Overview

Revenue of $24.3 million in the first quarter of 2021, up 23%, compared to $19.8 million in the first quarter of 2020.
Strong quarterly SINUVA revenue of $2.4 million.
Global Balloon and Navigation portfolio generated revenue of $1.5 million.
Cash, cash equivalents, restricted cash, and... More